Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
A phase 2 trial of Linperlisib in Leukaemia, run by Institute of Hematology & Blood Diseases Hospital, China, now recruiting.
Overview
Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia is a phase 2 interventional study registered as NCT06224257 by Institute of Hematology & Blood Diseases Hospital, China, with 41 participants planned, started 2023-12-03 and due to reach its primary completion in 2025-10-31. Interventions recorded: Linperlisib. Conditions recorded: Relapsed/Refractory Large Granular T Lymphocytic Leukemia.
Linked to the drug Linperlisib because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialA Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
Shares Linperlisib and the tag pipeline.
- TrialTreatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
Shares Leukaemia (all types) and the tag pipeline.
- TrialEfficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
Shares Leukaemia (all types) and the tag pipeline.
- TrialRasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2
Shares Leukaemia (all types) and the tag pipeline.
- TrialStudy of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL
Shares Leukaemia (all types) and the tag pipeline.
- TrialPhase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Shares Leukaemia (all types) and the tag pipeline.
- TrialMoxetumomab Pasudotox for Advanced Hairy Cell Leukemia
Shares Leukaemia (all types) and the tag pipeline.
- TrialInterleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
Shares Leukaemia (all types) and the tag pipeline.